APTX Stock Chart & Stats
C$35.76
-C$0.18(-0.50%)
At close: 4:00 PM EDT
C$35.76
-C$0.18(-0.50%)
Day’s Range― - ―
52-Week RangeC$26.05 - C$40.18
Previous CloseN/A
Volume197.25K
Average Volume (3M)N/A
Market Cap
C$8.36B
Enterprise ValueC$9.72B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)22.7
Beta0.32
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding228,499,020
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)-11.21
Price to Sales (P/S)1.79
P/FCF Ratio13.63
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$40.42Price Target Upside13.02% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
APTX FAQ
What was Apotex Health Corp.’s price range in the past 12 months?
Apotex Health Corp. lowest stock price was C$26.05 and its highest was C$40.18 in the past 12 months.
What is Apotex Health Corp.’s market cap?
Apotex Health Corp.’s market cap is C$8.36B.
When is Apotex Health Corp.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Apotex Health Corp.’s earnings last quarter?
Currently, no data Available
Is Apotex Health Corp. overvalued?
According to Wall Street analysts Apotex Health Corp.’s price is currently Undervalued.
Does Apotex Health Corp. pay dividends?
Apotex Health Corp. pays a Notavailable dividend of C$0.06 which represents an annual dividend yield of N/A. See more information on Apotex Health Corp. dividends here
What is Apotex Health Corp.’s EPS estimate?
Apotex Health Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Apotex Health Corp. have?
Apotex Health Corp. has 228,499,020 shares outstanding.
What happened to Apotex Health Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Apotex Health Corp.?
Currently, no hedge funds are holding shares in TSE:APTX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Apotex Health Corp. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Company Description
Apotex Health Corp.
Apotex Health Corp. operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India. The company develops, manufactures, and distributes a broad portfolio of prescription and generic pharmaceuticals, oncology biosimilar pharmaceuticals, branded specialty pharmaceuticals, and branded consumer health and wellness products. It operates through three business lines including conventional generic pharmaceuticals; specialty generic pharmaceuticals; and brands & biosimilars. The company has a a strategic partnership with Halo Pharmaceutical, Inc. The company was formerly known as Artemis Parent, Inc. and changed its name to Apotex Health Corp. in May 2026. Apotex Health Corp. was founded in 1974 and is headquartered in Toronto, Canada. Apotex Health Corp. operates as a subsidiary of SK Artemis Holdings, II, LLC
APTX Stock 12 Month Forecast
Average Price Target
C$40.42
▲(13.02% Upside)
Bausch Health Companies
―
Knight Therapeutics
―
Cipher Pharmaceuticals
―
CareRx
―
Medexus Pharmaceuticals Inc
―